128 related articles for article (PubMed ID: 4035555)
1. Long-term growth hormone responses to nonspecific hypothalamic hormones in acromegalic patients.
Watanabe M; Kuwayama A; Nakane T; Kanie N; Kato T; Takahashi T; Kageyama N
Surg Neurol; 1985 Oct; 24(4):449-56. PubMed ID: 4035555
[TBL] [Abstract][Full Text] [Related]
2. The natural course of growth hormone-secreting pituitary adenomas after surgery alone--clinical significance of the growth hormone response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone.
Mukada K
Neurol Med Chir (Tokyo); 1990 Apr; 30(4):251-7. PubMed ID: 1696695
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly.
Arosio M; Giovanelli MA; Riva E; Nava C; Ambrosi B; Faglia G
J Neurosurg; 1983 Sep; 59(3):402-8. PubMed ID: 6411870
[TBL] [Abstract][Full Text] [Related]
4. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
[TBL] [Abstract][Full Text] [Related]
5. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
[TBL] [Abstract][Full Text] [Related]
6. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
[TBL] [Abstract][Full Text] [Related]
7. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
9. Factors determining the long-term outcome of surgery for acromegaly.
Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
[TBL] [Abstract][Full Text] [Related]
10. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Hoyte KM; Martin JB
J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
[TBL] [Abstract][Full Text] [Related]
11. Acromegaly: reassessment of the long-term therapeutic effectiveness of transsphenoidal pituitary surgery.
Schuster LD; Bantle JP; Oppenheimer JH; Seljeskog EL
Ann Intern Med; 1981 Aug; 95(2):172-4. PubMed ID: 7258865
[TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy.
Tsuchiya H; Onishi T; Mogami H; Iida M
Endocrinol Jpn; 1990 Dec; 37(6):797-807. PubMed ID: 2129301
[TBL] [Abstract][Full Text] [Related]
13. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
14. Postoperative prognostic indicators of control of acromegaly.
Yamada S; Aiba T; Shishiba Y
Surg Neurol; 1989 Jan; 31(1):14-9. PubMed ID: 2645670
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
[TBL] [Abstract][Full Text] [Related]
16. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
17. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
19. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
20. Transient appearance of a provocative growth hormone response to L-dopa following incomplete adenomectomy in an acromegalic patient.
Takahara J; Yakushiji W; Yamuchi J; Miyoshi M; Hosogi H
J Clin Endocrinol Metab; 1977 Mar; 44(3):599-602. PubMed ID: 838854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
